lidoflazine has been researched along with Liver Cirrhosis in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zulik, R | 1 |
1 other study available for lidoflazine and Liver Cirrhosis
| Article | Year |
|---|---|
[Iatrogenic ventricular tachycardia].
Topics: Adams-Stokes Syndrome; Aged; Angina Pectoris; Female; Furosemide; Humans; Lidoflazine; Liver Cirrhos | 1979 |